A business in context

AGPU research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-23 · 8022 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-10-01 · 0001171843-26-006428

  2. 4 · Ownership change

    Report date 2026-10-01 · 0001171843-26-006427

  3. 4 · Ownership change

    Report date 2026-10-01 · 0001171843-26-006426

  4. 4 · Ownership change

    Report date 2026-10-01 · 0001171843-26-006425

  5. 4 · Ownership change

    Report date 2026-04-20 · 0001171843-26-006424

  6. 4 · Ownership change

    Report date 2026-10-01 · 0001171843-26-006423

  7. 8-K · Current report

    Report date 2026-09-30 · 0001171843-26-006386 · Items 1.01,7.01,9.01

  8. 8-K · Current report

    Report date 2026-09-11 · 0001171843-26-006093 · Items 1.01,2.01,9.01

  9. 4 · Ownership change

    Report date 2026-09-08 · 0001171843-26-005964

  10. 4 · Ownership change

    Report date 2026-07-01 · 0001171843-26-005963

  11. 8-K · Current report

    Report date 2026-08-17 · 0001171843-26-005581 · Items 8.01,9.01

  12. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001171843-26-005556

  13. 8-K · Current report

    Report date 2026-08-14 · 0001171843-26-005555 · Items 2.02,9.01

  14. 8-K · Current report

    Report date 2026-07-27 · 0001171843-26-004883 · Items 8.01,9.01

  15. 8-K · Current report

    Report date 2026-07-22 · 0001171843-26-004814 · Items 8.01,9.01

  16. 8-K · Current report

    Report date 2026-06-09 · 0001171843-26-004008 · Items 8.01,9.01

  17. 8-K · Current report

    Report date 2026-05-15 · 0001171843-26-003492 · Items 2.02,9.01

  18. 8-K · Current report

    Report date 2026-05-15 · 0001171843-26-003489 · Items 8.01,9.01

  19. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001171843-26-003484

  20. 8-K · Current report

    Report date 2026-05-11 · 0001171843-26-003313 · Items 7.01,9.01

  21. 8-K · Current report

    Report date 2026-04-22 · 0001171843-26-002636 · Items 8.01,9.01

  22. 8-K · Current report

    Report date 2026-04-10 · 0001171843-26-002517 · Items 5.02,9.01

  23. 8-K · Current report

    Report date 2026-04-01 · 0001171843-26-002182 · Items 5.02,8.01,9.01

  24. 8-K · Current report

    Report date 2026-03-31 · 0001171843-26-002096 · Items 2.02,9.01

  25. 10-K · Annual report

    Report date 2025-12-31 · 0001171843-26-002094

  26. 8-K · Current report

    Report date 2026-03-09 · 0001171843-26-001424 · Items 5.02

  27. 8-K · Current report

    Report date 2026-02-06 · 0001171843-26-000690 · Items 5.02,7.01,9.01

  28. 8-K · Current report

    Report date 2026-01-15 · 0001171843-26-000387 · Items 5.02,9.01

  29. 8-K · Current report

    Report date 2025-12-10 · 0001171843-25-007923 · Items 5.02,7.01,9.01

  30. 8-K · Current report

    Report date 2025-12-09 · 0001171843-25-007861 · Items 5.03,9.01

  31. 8-K · Current report

    Report date 2025-12-01 · 0001171843-25-007724 · Items 8.01,9.01

  32. 8-K · Current report

    Report date 2025-11-25 · 0001171843-25-007595 · Items 5.02,5.07,9.01

  33. 8-K · Current report

    Report date 2025-11-20 · 0001171843-25-007488 · Items 8.01

  34. 8-K · Current report

    Report date 2025-11-17 · 0001171843-25-007372 · Items 7.01,9.01

  35. 8-K · Current report

    Report date 2025-11-14 · 0001171843-25-007344 · Items 2.02,9.01

  36. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001171843-25-007342

  37. 8-K · Current report

    Report date 2025-10-29 · 0001171843-25-006772 · Items 8.01,9.01

  38. DEF 14A · Proxy statement

    Report date 2025-11-25 · 0001171843-25-006678

  39. 8-K · Current report

    Report date 2025-10-16 · 0001171843-25-006489 · Items 5.08

  40. 8-K · Current report

    Report date 2025-10-07 · 0001171843-25-006348 · Items 7.01,8.01,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-23 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 2 transaction rows2PSale: 0 transaction rows0SGrant / award: 5 transaction rows5AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

7 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-09-08
2026-09-09
Zhu TheodoreP · Purchase
Acquired
Common Stock3750.011.72
2026-09-08
2026-09-09
Zhu TheodoreP · Purchase
Acquired
Common Stock5000.010.88
2026-07-01
2026-09-09
Zhu TheodoreA · Grant / award
Acquired
Common Stock2420.00.0
2026-07-01
2026-09-09
ST. CLAIR GREGORY SRA · Grant / award
Acquired
Common Stock2420.00.0
2026-07-01
2026-09-09
Nuzum Charles Lee SrA · Grant / award
Acquired
Common Stock2420.00.0
2026-07-01
2026-09-09
Hawryluk MatthewA · Grant / award
Acquired
Common Stock1716.00.0
2026-07-01
2026-09-09
HANDLEY DANIEL EA · Grant / award
Acquired
Common Stock1716.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-10-23 · 1658 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001446159Axe Compute Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-23 · 1197 checked identities; 0 unavailable records

Search names and former names
  • Predictive Oncology Inc. · former SEC name · 2019-06-13 to 2025-12-11
  • Precision Therapeutics Inc. · former SEC name · 2018-04-02 to 2019-06-04
  • Skyline Medical Inc. · former SEC name · 2013-08-08 to 2018-02-06
  • BioDrain Medical, Inc. · former SEC name · 2008-11-12 to 2013-08-07

Revenue in constant purchasing power

USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$84.8K$91.1K
2023-12-31$1.63M$1.80M
2022-12-31$1.51M$1.73M
2021-12-31$1.42M$1.77M
2020-12-31$1.25M$1.63M
2019-12-31$1.41M$1.86M
2018-12-31$1.41M$1.89M
2017-12-31$654.8K$900.1K

Bureau of Labor Statistics · retrieved 2026-10-23 · 9 selected series; gaps remain missing

Explore the CPI history ↗